Grand Rounds in UrologyBest Practice and Leading Edge Knowledge for the Treatment of Urologic Disease
The mission of Grand Rounds in Urology™ (GRU) is to be the largest, most engaged urology professional community in the world, delivering the best practice information to improve physician performance and, ultimately, better patient outcomes. E. David Crawford, MD, Professor of Surgery, Urology, and Radiation Oncology, and Head of the Section of Urologic Oncology at the University of Colorado Denver in Denver, Colorado, serves as Editor in Chief.
Live Meetings: GRU is an organizer and host of international conferences and symposia that bring together the top thought leaders in the treatment of urologic disease. Our meetings focus on current best treatment practices as well as future trends and directions. These educational programs offer highly interactive dialog with state of the art presentations.
Valuable Information and Online Learning Products: Virtual Grand Rounds, Platinum Lecture Series, Ask the Expert, as well as presentations from international meetings provide the resources urologists need to stay informed. Online courses, CME and non-CME, provide urologists with the best practices for treating patients.
Networking: GRU serves to constantly connect professional learners, faculty experts, and industry partners through its’ live and virtual activities. These opportunities facilitate high-level collaborations to evolve best practices in urologic care.
GRU is published by Carden Jennings Publishing Co., Ltd., an internationally recognized medical publisher and award-winning producer of medical education materials for healthcare professionals in a variety of specialties.
Follow us on Twitter!
Rivanna Health Publication’s Prostatepedia features informal conversations with doctors, patients, and activists about prostate cancer about prostate cancer. Each month we tackle a different topic facing prostate cancer patients today—from how imaging has impacted treatment to dealing with erectile dysfunction after radiation or surgery to the evolving field of immunotherapy.